Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-12

Clinical Trial Update: Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 efficacy and safety study of NP000888 in plaque psoriasis and nail psoriasis has completed. The provided snippet does not include efficacy or safety res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NP000888

Snippet

Sponsor: Galderma R&D | Conditions: Psoriasis | Phase 2 | Status: COMPLETED